---  
layout: startup_page  
title: "Rege Nephro"  
id: "regenephro.co.jp"  
permalink: "/regenephroregenephro.co.jp10082024/"  
website: "https://www.regenephro.co.jp/en"  
funding_round: "Series B"  
funding_amount: "$15M"  
investors: "DCI Partners Co., Ltd., JIC Venture Growth Investments Co., Ltd., Nippon Venture Capital CO., Ltd., TOHOKU University Venture Partners Co., Ltd., Golden Asia Fund Ventures Ltd., Mitsui Chemicals, Inc., Global Brain Corporation, Kyoto University Innovation Capital Co., Ltd., JAFCO Group Co., Ltd., Mitsubishi UFJ Capital Co., Ltd., ASAHI KASEI CORPORATION, QB Capital, LLC"  
about: "Rege Nephro Co., Ltd. is a clinical-stage biotech company developing therapeutics and cell therapy for kidney, liver, and pancreas diseases using induced pluripotent stem cell (iPSC)-based technology from Kyoto University's CiRA. Their current focus is on RN-014 for ADPKD and RN-032 for CKD."  
markets: "Biotechnology, Pharmaceuticals, Cell Therapy, Biotechnology Research"  
hq: "Kyoto, Kyoto Prefecture, Japan"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/rege-nephro"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/rege-nephro?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase"  
pitchbook: "https://pitchbook.com/profiles/company/464198-41"  

date_display: "08-Oct-2024"  
date: "2024-10-08"

# SEO Optimization  
meta_title: "Rege Nephro - Series B Funding ($15M)"  
meta_description: "Rege Nephro, Rege Nephro Co., Ltd. is a clinical-stage biotech company developing therapeutics and cell therapy for kidney, liver, and pancreas diseases using indu..."  
meta_keywords: "Rege Nephro, Biotechnology, Pharmaceuticals, Cell Therapy, Biotechnology Research, Series B funding"  
canonical_url: "https://startup.projectstartups.com/regenephroregenephro.co.jp10082024/"  
---